Immune-mediated disorder management with targeted biologic and small molecule therapies — the monoclonal antibodies, fusion proteins, and oral kinase inhibitors modulating specific inflammatory pathways in rheumatoid arthritis, psoriasis, inflammatory bowel disease, and multiple sclerosis representing the fastest-evolving segment in immunology — creates the most therapeutically...